Inhibition of DNA, RNA and protein synthesis and chromatin alteration by N-hydroxyphenacetin

References

• BENGTSSON, U., JOHANSSON, S., and ANGERVAL L., 1978, Malignancies of the urinary tract and their relation to analgesic abuse. Kidney International, 13, 107–113.
   PubMed Web of Science ®Google Scholar
• BRUNNER, F. P., GIESECKE, B., GURLAND, H. J., JAcoss, C., PARSONS, F. M., SCHARER, K., SEYFFART, G., SPIES, G., and WING, W. J., 1975, Combined report on renal dialysis and transplantation in Europe. Proceedings of the European Dialysis and Transplant Association, 12, 3–64.
   Google Scholar
• CALDER, I. C., CREEK, M. J., WILLIAMS, P. J., FUNDER, C. C., GREEN C. R., HAM, K. N., and TANGE, J. D., 1973, N-hydroxylation of p-acetophenetidide as a factor in nephrotoxicity. Journal of Medicinal Chemistry, 16, 499–502.
   Google Scholar
• CALDER, I. C., CREEK, J. M., WILLIAMS, P. J., FUNDER, C. C., GREEN, C. R., HAM, K. N. and TANGE, J. D., 1976, Neoplasia in the rat induced by N-hydroxyphenacetin, a metabolite of phenacetin. Pathology, 8, 1–6.
   PubMed Web of Science ®Google Scholar
• CARRO-CIAMPI, G., 1978, Phenacetin abuse: a review. Toxicology, 10, 311–339.
   PubMed Web of Science ®Google Scholar
• COOK, P. R., and BRAZELL, I. R., 1975, Supercoils in human DNA. Journal of Cell Science, 19, 261–279.
   PubMed Web of Science ®Google Scholar
• HAYWARD, N. K., LAVIN, M. F., and CRASWEI.L, P., 1982, Inhibition of DNA synthesis and alteration to DNA structure by the phenacetin analog p-aminophenol. Biochemical Pharmacology, 31, 1425–1429.
   Google Scholar
• HAYWARD, N. K., CALDER, I. C., and LAVIN, M. F., 1986, Effect of N-hydroxyparacetamol on DNA, RNA and protein synthesis and chromatin structure. Molecular Pharmacology, 29, 478–483.
   PubMedGoogle Scholar
• HINSON, J. A., and MITCHELL, J. R., 1976, N-hydroxylation of phenacetin by hamster liver microsomes. Drug Metabolism and Disposition, 4, 430–435.
   PubMed Web of Science ®Google Scholar
• HINSON, J. A., Pcitn.., L. R., and GILLETTE, J. R., 1979, N-hydroxyacetaminophen: a microsomal metabolite of N-hydroxyphenacetin but apparently not of acetaminophen. Life Sciences, 24, 2133–2138.
   Google Scholar
• HOULDSWORTH, J., and LAVIN, M. F., 1980, Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia cells. Nucleic Acids Research, 8, 3709–3220.
   PubMed Web of Science ®Google Scholar
• HULTENGREN, N., LAGERGREN, C., and LJUNGQVIST, A., 1965, Carcinoma of the renal pelvis in renal papillary necrosis. Acta Chirurgica Scandinavica, 130, 314–320.
   PubMedGoogle Scholar
• KINCAID-SMITH, P., 1967, The pathogenesis of the lesions associated with analgesic abuse. The Lancet, 1, 859–862.
   PubMed Web of Science ®Google Scholar
• KOHN, K. W., 1979, DNA as a target in cancer chemotherapy: measurement of macromolecular DNA damage produced in mammalian cells by anticancer agents and carcinogens. Methods in Cancer Research, 16, 291–345.
   Google Scholar
• MAHONEY, J. F., STOREY, B. G., IBANEZ, R., and STEWART, J. H., 1977, Analgesic abuse, renal parenchymal disease and carcinoma of the kidney or ureter. Australian and New Zealand Journal of Medicine, 7,463–469.
   PubMedGoogle Scholar
• MANIATIS, T., FRITSCH, E. F., and SAMBROOK, J., 1982, Molecular Cloning: A Laboratory Manual (CSH Press: Cold Spring Harbour Laboratory), p. 368.
   Google Scholar
• MANNION, R. A., and SUSMANO, D., 1971, Phenacetin abuse causing bladder tumor. The Journal of Urology, 106, 692.
   PubMedGoogle Scholar
• MILLER, J. A., 1970, Carcinogenesis by chemicals: an overview—G. H. A. Clowes Memorial Lecture. Cancer Research, 30, 559–576.
   PubMed Web of Science ®Google Scholar
• NERY, R., 1971, The possible role of N-hydroxylation in the biological effects of phenacetin. Xenobiotica, 1, 339–343.
   PubMedGoogle Scholar
• NOHMI, T., YOSHIKAWA, K., NARADATE, M., and ISHIDATE, M., 1983, Species difference in the metabolic activation of phenacetin by rat and hamster liver microsomes. Biochemical and Biophysical Research Communications, 110, 746–752.
   PubMedGoogle Scholar
• NORDENFEI.T, O., and RINGERTZ, N., 1961, Phenacetin takers dead with renal failure. Acta Medico Scandinavica, 179, 385–387.
   Google Scholar
• ORELL, S. R., NANRA, R. S., and FERGUSON, N. W., 1979, Renal pelvic carcinoma in the Hunter Valley. Medical Journal of Australia, 2, 555–557.
   Google Scholar
• PAINTER, R. B., 1977, Rapid test to detect agents that damage human DNA. Nature, 265,650–651.
   PubMed Web of Science ®Google Scholar
• PAINTER, R. B., and HOWARD, R., 1978, A comparison of the Hela DNA-synthesis inhibition test and the Ames test for screening of mutagenic carcinogens. Mutation Research, 54, 113–115.
   PubMedGoogle Scholar
• PREscorr, L. F., 1980, Kinetics and metabolism of paracetamol and phenacetin. British Journal of Clinical Pharmacology, 10, 291S–298S.
   Google Scholar
• PREscorr, L. F., 1982, Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics. Drugs, 23,75–149.
   PubMedGoogle Scholar
• RAAFLAUB, J., and DUBACH, U., 1969, Neue aspekte zur frage der nephrotoxizitat von phenacetin. Experientia, 25,956–958.
   PubMedGoogle Scholar
• SHUDO, K., OHTA, T., ORIHARA, V., OKAMATO, T., NAGAO, M., TAKAHASHI, Y., and SUGIMARA, T., 1978, Mutagenicities of phenacetin metabolites. Mutation Research, 58, 367–370.
   PubMedGoogle Scholar
• SMITH, R. L., and TIMBRELL, J. A., 1974, Factors affecting the metabolism of phenacetin II. Effect of aspirin, caffeine, codeine, ethanol, and phenobarbital on the metabolism of [acetyl-"C]phenacetin in the rat. Xenobiotica, 4,503–508.
   PubMed Web of Science ®Google Scholar
• THORGEIRSSON, S. S., FELTON, J. S., and NEBERT, D. W., 1975, Genetic differences in the aromatic hydrocarbon-inducible N-hydroxylation of 2-acetylaminofluorene and acetaminophen-produced hepatotoxicity in mice. Molecular Pharmacology, 11, 159–165.
   PubMed Web of Science ®Google Scholar
• VAUGHT, J. B., MCGARVEY, P. B., LEE, M., GARNER, C. D., WANG, C. Y., LINSMAIER-BEDNAR, E. M., and KING, C. M., 1981, Activation of N-hydroxyphenacetin to mutagenic and nucleic acid binding metabolites by acyl transfer, deacetylation, and sulphate conjugation. Cancer Research, 41, 3424–3429,
   Google Scholar
• WIRTH, P. J., DYBING, E., VON BAHR, C., and THORGIERSSON, S. S., 1980, Mechanism of N-hydroxyacetylarylamine mutagenicity in the Salmonella test system: metabolic activation of N-hydroxyphenacetin by liver and kidney fractions from rat, mouse, hamster and Man. Molecular Pharmacology, 18,117–127.
   PubMed Web of Science ®Google Scholar
• ZOLLINGER, H. U., and SPUHLER, O., 1950, Die nicht-eitrige, chronische interstitielle nephritis. Schweizerische Zeitschrift fur Allgemeine Pathologie und Bakteriologie, 13, 807.
   PubMedGoogle Scholar